Further, according to the present meta-analysis, the prevalence of lymph node metastasis was increased in patients with BRAF mutation, with an odds ratio of 1.45; increased risk was observed in 39 of 60 studies. Here, BRAF is linked to metastatic malignant neoplasm in the lymph nodes.